Menu
 
Research menu
Jump to menu

Publications:  Prof Janet Jones

Brockmoeller S, Young C, Lee J, Arends MJ, Wilkins BS, Thomas GJ, Oien KA, Jones L et al. (2019). Survey of UK histopathology consultants' attitudes towards academic and molecular pathology. J Clin Pathol.
10.1136/jclinpath-2018-205568
Coulson-Gilmer C, Humphries MP, Sundara Rajan S, Droop A, Jackson S, Condon A, Cserni G, Jordan LB et al.(2018). Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer. J Pathol Clin Res vol. 4, (4) 241-249.
10.1002/cjp2.106
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54818
Moore DA, Young CA, Morris HT, Oien KA, Lee JL, Jones JL, Salto-Tellez M(2018). Time for change: a new training programme for morpho-molecular pathologists?. J Clin Pathol vol. 71, (4) 285-290.
10.1136/jclinpath-2017-204821
Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker A-M, Kapitonova E, Bakhouche BA, Tanner Y et al.(2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Rep vol. 22, (9) 2469-2481.
10.1016/j.celrep.2018.02.028
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56422
Pollard J, Burns PA, Hughes TA, Ho-Yen C, Jones JL, Mukherjee G, Omoniyi-Esan GO, Titloye NA et al.(2018). Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities. Pathobiology vol. 85, (4) 220-226.
10.1159/000488456
Pearce OMT, Delaine-Smith R, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D et al.(2017). Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov
10.1158/2159-8290.CD-17-0284
https://qmro.qmul.ac.uk/xmlui/handle/123456789/30984
Jones JL, Oien KA, Lee JL, Salto-Tellez M(2017). Morphomolecular pathology: setting the framework for a new generation of pathologists. Br J Cancer vol. 117, (11) 1581-1582.
10.1038/bjc.2017.340
Saunderson EA, Stepper P, Gomm JJ, Hoa L, Morgan A, Allen MD, Jones JL, Gribben JG et al.(2017). Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors. Nat Commun vol. 8, (1)
10.1038/s41467-017-01078-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/29503
Nelan RL, Hayward MK, Jones JL(2017). The growth of molecular diagnostics: Stratified Medicine Programme, the 100,000 Genomes Project and the future. Diagnostic Histopathology vol. 23, (10) 458-467.
10.1016/j.mpdhp.2017.09.001
Humphries MP, Sundara Rajan S, Droop A, Suleman CAB, Carbone C, Nilsson C, Honarpisheh H, Cserni G et al.(2017). A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer. Clin Cancer Res vol. 23, (10) 2575-2583.
10.1158/1078-0432.CCR-16-1952
Carter EP, Gopsill JA, Gomm JJ, Jones JL, Grose RP(2017). A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer. Breast Cancer Res vol. 19, (1)
10.1186/s13058-017-0843-4
Humphries MP, Sundara Rajan S, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL et al.(2017). Characterisation of male breast cancer: a descriptive biomarker study from a large patient series. Sci Rep vol. 7,
10.1038/srep45293
Sarper M, Allen MD, Gomm J, Haywood L, Decock J, Thirkettle S, Ustaoglu A, Sarker S-J et al.(2017). Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Res vol. 19, (1)
10.1186/s13058-017-0822-9
Ironside A, Hawkesford K, Gomm J, Haywood L, Goulding I, Wang J, Lamaziere A, Poirot M et al. (2017). Molecular mediators of mammographic density. CANCER RESEARCH. vol. 77,
10.1158/1538-7445.SABCS16-P4-15-04
Patel H, Abduljabbar R, Lai C-F, Periyasamy M, Harrod A, Gemma C, Steel JH, Patel N et al.(2016). Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer. Clin Cancer Res vol. 22, (23) 5929-5938.
10.1158/1078-0432.CCR-15-1104
Hayward M, Allen MD, Dreger S, Marshall JF, Jones JL (2016). Investigating the Functional Significance of Aberrant alpha v beta 6 and Fibronectin Expression in Myoepithelial Cells: Role in the Progression of DCIS?. JOURNAL OF PATHOLOGY. vol. 240, 28-28.
Ironside A, Gomm J, Haywood L, Goulding I, Wang J, Guerra A, Chelala C, Jones JL (2016). Molecular Mediators of Mammographic Density. JOURNAL OF PATHOLOGY. vol. 240, 12-12.
10.1158/1538-7445.SABCS16-P4-15-04
Jones JL, Gomm J, Haywood L, Morgan A, Goulding I, Allen M, Chelala C, Gadelata E (2016). Breast Cancer Now Cell Culture Programme: a bespoke resource for the research community. Breast Cancer Research and Treatment. Conference: UK Breast Cancer Research Symposium 2016 from: 22/07/2016 to: 23/07/2016, vol. 159, 196-196.
10.1007/s10549-016-3898-5
Ironside A, Gomm J, Haywood L, Goulding I, Wang J, Chelala C, Jones JL (2016). Molecular mediators of mammographic density. BREAST CANCER RESEARCH AND TREATMENT. vol. 159, 182-183.
10.1158/1538-7445.SABCS16-P4-15-04
Morrissey B, Blyth K, Carter P, Chelala C, Jones L, Holen I, Speirs V(2016). SEARCHBreast: A new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers. Breast Cancer Research vol. 18, (1)
10.1186/s13058-016-0716-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36339
Ironside AJ, Jones JL(2016). Stromal characteristics may hold the key to mammographic density: the evidence to date. Oncotarget vol. 7, (21) 31550-31562.
10.18632/oncotarget.6912
Purrington KS, Visscher DW, Wang C, Yannoukakos D, Hamann U, Nevanlinna H, Cox A, Giles GG et al.(2016). Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes. Breast Cancer Res Treat vol. 157, (1) 117-131.
10.1007/s10549-016-3775-2
Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L et al.(2016). Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?. Breast vol. 26, 149-150.
10.1016/j.breast.2015.12.011
Clarke CJ, Berg TJ, Birch J, Ennis D, Mitchell L, Cloix C, Campbell A, Sumpton D et al.(2016). The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis. Curr Biol vol. 26, (6) 755-765.
10.1016/j.cub.2016.01.045
Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L et al.(2016). Genetic testing in a cohort of young patients with HER2-amplified breast cancer. Ann Oncol vol. 27, (3) 467-473.
10.1093/annonc/mdv592
Ironside A, Gomm J, Haywood L, Dreger S, Allen M, Guerra A, Wang J, Chelala C et al. (2015). Molecular Mediators of Mammographic Density. JOURNAL OF PATHOLOGY. vol. 237, S18-S18.
10.1158/1538-7445.SABCS16-P4-15-04
Downey CL, Simpkins SA, Holliday DL, Jones JL, Jordan LB, Kulka J, Hanby AM, Speirs V(2015). Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'. Br J Cancer vol. 112, (11) 1833-1834.
10.1038/bjc.2014.571
Ho-Yen CM, Jones JL, Kermorgant S(2015). The clinical and functional significance of c-Met in breast cancer: a review. Breast Cancer Res vol. 17,
10.1186/s13058-015-0547-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15970
Millican-Slater R, Good R, Nash C, Heads JA, Pollock S, Chalkley R, Gomm J, Jones JL et al.(2015). Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient. Cell and tissue banking vol. 16, (1) 27-34.
10.1007/s10561-014-9444-y
Millican-Slater R, Good R, Nash C, Heads JA, Pollock S, Chalkley R, Gomm J, Jones JL et al.(2015). Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient. Cell Tissue Bank vol. 16, (1) 27-34.
10.1007/s10561-014-9444-y
Laversin SA, Krishnan J, Schapira A, Dou L, Ashton-Key M, Jones JL, Allen MD, Glennie MJ et al.(2014). Manipulation of macrophage Fc gamma receptors to improve antibody immunotherapy of HER2+breast cancer. IMMUNOLOGY vol. 143, 128-129.
Allen MD, Marshall JF, Jones JL(2014). αvβ6 Expression in myoepithelial cells: a novel marker for predicting DCIS progression with therapeutic potential. Cancer Res vol. 74, (21) 5942-5947.
10.1158/0008-5472.CAN-14-1841
Wong P-P, Yeoh CC, Ahmad AS, Chelala C, Gillett C, Speirs V, Jones JL, Hurst HC(2014). Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer. Oncogene vol. 33, (37) 4579-4588.
10.1038/onc.2014.45
https://qmro.qmul.ac.uk/xmlui/handle/123456789/8519
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2014). Therapeutic targeting of integrin αvβ6 in breast cancer. J Natl Cancer Inst vol. 106, (8)
10.1093/jnci/dju169
https://qmro.qmul.ac.uk/xmlui/handle/123456789/8829
Elosegui-Artola A, Bazellières E, Allen MD, Andreu I, Oria R, Sunyer R, Gomm JJ, Marshall JF et al.(2014). Rigidity sensing and adaptation through regulation of integrin types. Nat Mater vol. 13, (6) 631-637.
10.1038/nmat3960
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6445
Downey CL, Simpkins SA, White J, Holliday DL, Jones JL, Jordan LB, Kulka J, Pollock S et al.(2014). The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer vol. 110, (7) 1744-1747.
10.1038/bjc.2014.69
Alexopoulou AN, Ho-Yen CM, Papalazarou V, Elia G, Jones JL, Hodivala-Dilke K(2014). Tumour-associated endothelial-FAK correlated with molecular sub-type and prognostic factors in invasive breast cancer. BMC Cancer vol. 14,
10.1186/1471-2407-14-237
Speirs V, Chelala C, Coates R, Jones JL, Matharoo-Ball B, Quinlan P (2014). The Breast Cancer Campaign Tissue Bank: Generating new biomaterials to accelerate breast cancer research. EUROPEAN JOURNAL OF CANCER. vol. 50, S200-S200.
Allen MD, Thomas GJ, Clark S, Dawoud MM, Vallath S, Payne SJ, Gomm JJ, Dreger SA et al.(2014). Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res vol. 20, (2) 344-357.
10.1158/1078-0432.CCR-13-1504
Ho-Yen CM, Green AR, Rakha EA, Brentnall AR, Ellis IO, Kermorgant S, Jones JL(2014). C-Met in invasive breast cancer: is there a relationship with the basal-like subtype?. Cancer vol. 120, (2) 163-171.
10.1002/cncr.28386
Endrizzi M, Diemoz PC, Millard TP, Jones JL, Speller RD, Robinson IK, Olivo A(2014). Hard X-ray dark-field imaging with incoherent sample illumination. APPLIED PHYSICS LETTERS vol. 104, (2) Article ARTN 024106,
10.1063/1.4861855
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2013). Integrin avb6 is a therapeutic target for high-risk breast cancer and enhances trastuzumab efficacy. CANCER RESEARCH vol. 73,
10.1158/0008-5472.SABCS13-P4-15-01
Pollard JA, Burns PA, Hughes TA, Mukherjee G, Jones JL, Ho-Yen C, Esan GOO, Titloye NA et al. (2013). Differential Expression of MicroRNAs in Breast Cancers From Four Different Ethnicities. JOURNAL OF PATHOLOGY. vol. 231, 24-24.
Olivo A, Gkoumas S, Endrizzi M, Hagen CK, Szafraniec MB, Diemoz PC, Munro PRT, Ignatyev K et al.(2013). Low-dose phase contrast mammography with conventional x-ray sources. MEDICAL PHYSICS vol. 40, (9) Article ARTN 090701,
10.1118/1.4817480
Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R et al.(2013). Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain vol. 136, (Pt 9) 2888-2903.
10.1093/brain/awt182
Gaynor K, Grigorieva I, Allen MD(2013). GATA3 Mutations Found in Breast Cancers May Be Associated with Aberrant Nuclear Localization, Reduced Transactivation and Cell Invasiveness. Hormones and Cancer vol. Volume 4, (3) 123-139.
10.1007/s12672-013-0138-x
Ho-Yen C, Bowen RL, Kermorgant S, Jones JL(2013). Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'. Br J Cancer vol. 108, (10) 2195-2196.
10.1038/bjc.2013.249
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15971
Robbez-Masson LJ, Bödör C, Jones JL, Hurst HC, Fitzgibbon J, Hart IR, Grose RP(2013). Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. PLoS One vol. 8, (11)
10.1371/journal.pone.0078839
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13790
Elosegui-Artola A, Bazellieres E, Allen MD, Andreu I, Marshall JF, Jones JL, Trepat X, Roca-Cusachs P(2013). Rigidity sensing and adaptation through regulation of integrin populations. MOLECULAR BIOLOGY OF THE CELL vol. 24,
Verma R, Bowen RL, Slater SE, Mihaimeed F, Jones JL(2012). Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer. Br Med Bull vol. 103, (1) 129-145.
10.1093/bmb/lds018
Dreger SA, Payne SJ, Dawoud M, Robinson SD, Marshall JF, Hodivala-Dilke KM, Allen MD, Jones JL (2012). Up-regulation of alpha v beta 6 integrin and fibronectin EDA in myoepithelial cells contribute to the angiogenic switch in pre-invasive breast cancer. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. vol. 93, A24-A24.
Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, Dent J, Fulford L, Honarpisheh H et al.(2012). A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. BREAST CANCER RESEARCH AND TREATMENT vol. 133, (3) 949-958.
10.1007/s10549-011-1856-9
Ahmed KO, Allen M, Gomm J, Marshall J, Jones JL (2012). MYOEPITHELIAL CONTROL OF THE INFLAMMATORY MICROENVIRONMENT PROMOTES TRANSITION OF DCIS TO INVASIVE DISEASE. ANNALS OF ONCOLOGY. vol. 23, 19-19.
Shaw EC, Hanby AM, Wheeler K, Shaaban AM, Poller D, Barton S, Treanor D, Fulford L et al.(2012). Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study. JOURNAL OF CLINICAL PATHOLOGY vol. 65, (5) 403-408.
10.1136/jclinpath-2011-200369
Jones JL (2012). Breast Cancer - The Beginning. JOURNAL OF PATHOLOGY. vol. 226, S2-S2.
Hill-Cawthorne GA, Button T, Tuohy O, Jones JL, May K, Somerfield J, Green A, Giovannoni G et al.(2012). Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY vol. 83, (3) 298-304.
10.1136/jnnp-2011-300826
Sarper M, Allen M, Decock J, Marshall JF, Edwards DR, Jones JL (2012). Loss of MMP-8 Expression Contributes to Altered Myoepithelial Cell Function in DCIS. JOURNAL OF PATHOLOGY. vol. 226, S13-S13.
Jones DT, Lechertier T, Mitter R, Herbert JMJ, Bicknell R, Jones JL, Li J-L, Buffa F et al.(2012). Gene expression analysis in human breast cancer associated blood vessels. PLoS One vol. 7, (10)
10.1371/journal.pone.0044294
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5434
Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM(2011). Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J MED GENET vol. 48, (8) 520-522.
10.1136/jmedgenet-2011-100006
Allen MD, Vaziri R, Green M, Chelala C, Brentnall AR, Dreger S, Vallath S, Nitch-Smith H et al.(2011). Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasion. J Pathol vol. 223, (5) 646-658.
10.1002/path.2833
Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL(2011). Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer vol. 104, (1) 120-127.
10.1038/sj.bjc.6606021
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M et al.(2011). Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. BREAST CANCER RESEARCH vol. 13, (6) Article ARTN R110,
10.1186/bcr3052
https://qmro.qmul.ac.uk/xmlui/handle/123456789/4920
Allen M, Jones JL(2011). Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J PATHOL vol. 223, (2) 162-176.
10.1002/path.2803
Wilson JRF, Bateman AC, Hanson H, An Q, Evans G, Rahman N, Jones JL, Eccles DM(2010). A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. J MED GENET vol. 47, (11) 771-774.
10.1136/jmg.2010.078113
Pani S, Cook EJ, Horrocks JA, Jones JL, Speller RD(2010). Characterization of breast tissue using energy-dispersive X-ray diffraction computed tomography. Appl Radiat Isot vol. 68, (10) 1980-1987.
10.1016/j.apradiso.2010.04.027
da Silva RG, Tavora B, Robinson SD, Reynolds LE, Szekeres C, Lamar J, Batista S, Kostourou V et al.(2010). Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF. Am J Pathol vol. 177, (3) 1534-1548.
10.2353/ajpath.2010.100043
Willis L, Alarcón T, Elia G, Jones JL, Wright NA, Tomlinson IPM, Graham TA, Page KM(2010). Breast cancer dormancy can be maintained by small numbers of micrometastases. Cancer Res vol. 70, (11) 4310-4317.
10.1158/0008-5472.CAN-09-3144
Novitskaya V, Romanska H, Dawoud M, Jones JL, Berditchevski F(2010). Tetraspanin CD151 Regulates Growth of Mammary Epithelial Cells in Three-Dimensional Extracellular Matrix: Implication for Mammary Ductal Carcinoma In situ. CANCER RES vol. 70, (11) 4698-4708.
10.1158/0008-5472.CAN-09-4330
Germain M, De Arcangelis A, Robinson SD, Baker M, Tavora B, D'Amico G, Silva R, Kostourou V et al.(2010). Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis. J Pathol vol. 220, (3) 370-381.
10.1002/path.2654
Guttery DS, Hancox RA, Mulligan KT, Hughes S, Lambe SM, Pringle JH, Walker RA, Jones JL et al.(2010). Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res vol. 12, (4)
10.1186/bcr2618
Holliday DL, Maltby S, Moss MA, Hanby AM, Jones JL, Speirs V (2010). Modelling breast cancer in a three-dimensional heterotypic culture system. BREAST CANCER RESEARCH. vol. 12, S18-S18.
10.1186/bcr2556
Cunha POR, Ornstein M, Jones JL(2010). Progression of Ductal Carcinoma in Situ from the Pathological Perspective. BREAST CARE vol. 5, (4) 233-239.
10.1159/000319625
Holliday DL, Brouilette KT, Markert A, Jones JL (2009). A HUMAN HETEROTYPIC BREAST MODEL FOR TRANSLATIONAL STUDIES OF DUCTAL CARCINOMA IN SITU (DCIS) PROGRESSION. ANNALS OF ONCOLOGY. vol. 20, 40-40.
Middleton RK, Bown MJ, Lloyd GM, Jones JL, London NJ, Sayers RD(2009). Characterisation of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation. Eur J Vasc Endovasc Surg vol. 37, (1) 46-55.
10.1016/j.ejvs.2008.09.013
Holliday DL, Brouilette KT, Markert A, Gordon LA, Jones JL(2009). Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression. BREAST CANCER RES vol. 11, (1) Article R3,
10.1186/bcr2218
Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA et al.(2009). Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Res vol. 11, (2)
10.1186/bcr2251
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6705
Mintz PJ, Habib NA, Jones JL, Giamas G, Lewis JS, Bowen RL, Coombes RC, Stebbing J(2008). The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer. CANCER vol. 113, (6) 1489-1495.
10.1002/cncr.23699
Duffy SW, Bowen RL, Ryan DA, Hart IR, Jones JL(2008). Reply: Early onset of breast cancer in black British women: how reliable are the findings?. BRIT J CANCER vol. 99, (6) 988-988.
10.1038/sj.bjc.6604626
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Reply: Early onset of breast cancer in British black women. British Journal of Cancer vol. 98, (12)
10.1038/sj.bjc.6604416
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Early onset of breast cancer in British black women - Reply. BRIT J CANCER vol. 98, (12) 2012-2012.
10.1038/sj.bjc.6604416
Bowen R, Duffy S, Ryan D, Hart I, Jones L(2008). Reply: Early onset breast cancer in black British women: a letter to the editor of British Journal of Cancer regarding early onset of breast cancer in a group of British black women. BRIT J CANCER vol. 98, (8) 1483-1484.
10.1038/sj.bjc.6604337
Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL et al.(2008). Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. CANCER RES vol. 68, (8) 2755-2763.
10.1158/0008-5472.CAN-07-5154
Salama I, Malone PS, Mihaimeed F, Jones JL(2008). A review of the S100 proteins in cancer. EJSO-EUR J SURG ONC vol. 34, (4) 357-364.
10.1016/j.ejso.2007.04.009
Varghese P, Gattuso JM, Mostafa AIH, Abdel-Rahman AT, Shenton KC, Ryan DA, Jones JL, Wells CA et al.(2008). The role of radiotherapy in treating small early invasive breast cancer. Eur J Surg Oncol vol. 34, (4) 369-376.
10.1016/j.ejso.2007.04.008
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Early onset of breast cancer in a group of British black women. BRIT J CANCER vol. 98, (2) 277-281.
10.1038/sj.bjc.6604174
Modes V, Rodrigues CM, Nyquist N, Shaw JA, Jones JL, Walker RA (2008). Altered myoepithelial cell expression and function in cancer-containing breasts. BREAST CANCER RESEARCH. vol. 10, S25-S25.
10.1186/bcr1931
Allen M, Mulligan K, Clark S, Hart I, Marshall JF, Jones JL (2008). De novo expression of alpha(v)beta(6) integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression. BREAST CANCER RESEARCH. vol. 10, S16-S16.
10.1186/bcr1912
Payne SJL, Bowen RL, Jones JL, Wells CA(2008). Predictive markers in breast cancer - the present. HISTOPATHOLOGY vol. 52, (1) 82-90.
10.1111/j.1365-2559.2007.02897.x
Holliday DL, Mulligan KT, Jones JL (2007). Development of in vitro models to study microenvironmental influences on breast cancer progression. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S201-S202.
Jones JL, Thomas GJ, Duffy SW, Gabe R, Ellis I, Green A, Saha A, Mulligan KT et al. (2007). Expression of alphavbeta6 supersedes Her2 and triple-negative/basal classification of breast cancer and defines novel subgroups with poor survival: implications for breast cancer classification and treatment. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S11-S11.
Clark SE, Marshall JE, Hart IR, Carpenter R, Jones JL (2007). Molecular profiling of DCIS: identification of distinct subgroups of potential prognostic importance. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S221-S221.
Alcock RA, Allen MD, Holliday DL, Edwards DR, Pennington CL, Shaw JA, Walker RA, Pringle JH et al. (2007). Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and proliferation through MMP-dependant and -independant mechanisms. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S200-S201.
Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL(2007). Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res vol. 13, (22 Pt 1) 6673-6680.
10.1158/1078-0432.CCR-07-0884
Hughes S, Jones JL(2007). The use of multiple displacement amplified DNA as a control for methylation specific PCR, pyrosequencing, bisulfite sequencing and methylation-sensitive restriction enzyme PCR. BMC Mol Biol vol. 8,
10.1186/1471-2199-8-91
Holliday DL, Hughes S, Shaw JA, Walker RA, Jones JL(2007). Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Res vol. 9, (5)
10.1186/bcr1775
Edwards JG, Swinson DEB, Jones JL, Waller DA, O'Byrne KJ(2006). EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma. LUNG CANCER vol. 54, (3) 399-407.
10.1016/j.lungcan.2006.08.012
Bowen RL, Stebbing J, Jones LJ(2006). A review of the ethnic differences in breast cancer. PHARMACOGENOMICS vol. 7, (6) 935-942.
10.2217/14622416.7.6.935
Hughes S, Holliday D, Shaw J, Duffy S, Hart I, Jones L (2006). Analysis of MMP single nucleotide polymorphisms in relation to breast cancer progression. JOURNAL OF PATHOLOGY. vol. 210, 58-58.
Lloyd K, Pringle JH, Alcock RA, Jones JL, Walker RA, Shaw JA (2006). Expression of invasion promoting Tn-C isoforms in DCIS. JOURNAL OF PATHOLOGY. vol. 210, 35-35.
Nitch-Smith HL, Walker R, Hart IR, Carpenter R, Jones JL (2006). Expression of the tenascin-binding alpha 9 beta 1 integrin in normal breast, DCIS and invasive breast cancer. JOURNAL OF PATHOLOGY. vol. 210, 31-31.
Wilson WRW, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PRF, Thompson MM(2006). Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation vol. 113, (3) 438-445.
10.1161/CIRCULATIONAHA.105.551572
Alcock RA, Pringle JH, Shaw JA, Holliday DL, Allen M, Walker RA, Jones JL (2006). Functional analysis of altered Tenascin isoform expression in breast cancer. BREAST CANCER RESEARCH. vol. 8, S11-S11.
10.1186/bcr1575
Allen M, Mulligan K, Clark S, Hart I, Marshall JF, Jones JL (2006). Functional analysis of normal and DCIS modified breast myoepithelial cells. BREAST CANCER RESEARCH. vol. 8, S9-S9.
10.1186/bcr1569
Jones JL(2006). Overdiagnosis and overtreatment of breast cancer - Progression of ductal carcinoma in situ: the pathological perspective. BREAST CANCER RES vol. 8, (2) Article 204,
10.1186/bcr1397
Grierson C, Holliday DL, Jameson JS, Pringle JH, Jones JL (2005). Tenascin-C isoform expression in colorectal cancer. JOURNAL OF PATHOLOGY. vol. 207, 39-39.
Wilson WRW, Schwalbe EC, Jones JL, Bell PRF, Thompson MM (2005). Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm. BRITISH JOURNAL OF SURGERY. vol. 92, 828-833.
10.1002/bjs.4993
Shah A, Swain WA, Richardson D, Edwards J, Stewart DJ, Richardson CM, Swinson DEB, Patel D et al.(2005). Phospho-Akt expression is associated with a favorable outcome in non-small cell lung cancer. CLIN CANCER RES vol. 11, (8) 2930-2936.
10.1158/1078-0432.CCR-04-1385
Sutton CD, Marshall LJ, Goddard JC, O'Byrne K, Garcia G, Jones JL, Dennison AR, Poston G et al. (2005). Hypoxia and angiogenesis in colorectal liver metastases. BRITISH JOURNAL OF SURGERY. vol. 92, 58-58.
Walker RA, Rodrigues CM, Gordon-Weeks A, Luckett JC, Jones JL (2005). Growth regulation is altered in cancer-containing breasts. BREAST CANCER RESEARCH AND TREATMENT. vol. 94, S283-S283.
Mulligan KT, Wang H, Shaw JA, Hart IR, Jones JL (2005). The tumour-suppressor function of breast myoepithelial cells is mediated in part through regulation of S100A9. BREAST CANCER RESEARCH AND TREATMENT. vol. 94, S285-S285.
Alcock RA, Holliday DL, Shaw JA, Walker RA, Pringle JH, Jones JL (2005). Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and proliferation. BREAST CANCER RESEARCH AND TREATMENT. vol. 94, S188-S188.
Alcock RA, Adams M, Pringle JH, Shaw JA, Walker RA, Jones JL (2004). Analysis of the functional significance of altered Tenascin isoform expression in breast cancer. JOURNAL OF PATHOLOGY. vol. 204, 3A-3A.
Luckett JCA, Shaw JA, Jones JL, Walker RA (2004). Signal transduction and cell cycle regulation by the breast myoepithelial cells. JOURNAL OF PATHOLOGY. vol. 204, 16A-16A.
Holliday DL, Shaw JA, Walker RA, Jones JL (2004). Stromal contribution to breast cancer cell invasion: Intrinsic genetic differences relate to invasion promoting ability. JOURNAL OF PATHOLOGY. vol. 204, 2A-2A.
Swinson DEB, Jones JL, Cox G, Richardson D, Harris AL, O'Byrne KJ(2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer vol. 111, (1) 43-50.
10.1002/ijc.20052
Molloy KJ, Thompson MM, Jones JL, Schwalbe EC, Bell PRF, Naylor AR, Loftus IM(2004). Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity. Circulation vol. 110, (3) 337-343.
10.1161/01.CIR.0000135588.65188.14
Sutton CD, Marshall LJ, Goddard JC, O'Byrne K, Garcia G, Jones JL, Dennison AR, Poston G et al. (2004). Biological factors influencing angiogenesis and prognosis in resected colorectal liver metastases. BRITISH JOURNAL OF SURGERY. vol. 91, 30-30.
Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, Girling AC, Ball RY, Edwards DR(2004). Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. CLIN CANCER RES vol. 10, (7) 2429-2440.
10.1158/1078-0432.CCR-0398-3
Jones JL, Shaw JA, Pringle JH, Walker RA(2003). Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol vol. 201, (4) 562-572.
10.1002/path.1483
Tai SK, Tan OJK, Chow VTK, Jin RX, Jones JL, Tan PH, Jayasurya A, Bay BH(2003). Differential expression of metallothionein 1 and 2 lsoforms in breast cancer lines with different invasive potential - Identification of a novel nonsilent metallothionein-1H mutant variant. AM J PATHOL vol. 163, (5) 2009-2019.
10.1016/S0002-9440(10)63559-6
Edwards JG, Swinson DEB, Jones JL, Muller S, Waller DA, O'Byrne KJ(2003). Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. CHEST vol. 124, (5) 1916-1923.
10.1378/chest.124.5.1916
Alcock RA, Shaw JA, Pringle JH, Walker RA, Jones JL (2003). Expression of tenascin AD1 domain in breast is not specific to malignancy. JOURNAL OF PATHOLOGY. vol. 201, 35A-35A.
Al Bahlani S, Shaw JA, Whyman G, Potter L, Walker RA, Jones JL (2003). Genetic alterations in epithelial and stromal cells of breast cancers and surrounds. JOURNAL OF PATHOLOGY. vol. 201, 5A-5A.
Gordon LA, Mulligan KT, Maxwell-Jones H, Adams M, Walker RA, Jones JL(2003). Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer vol. 106, (1) 8-16.
10.1002/ijc.11172
Marshall LJ, Sutton CD, Jones JL, O'Byrne K, Dennison AR, Poston G, Lloyd DM, Berry DP (2003). Carbonic anhydrase ix independently predicts survival in colorectal liver metastases. BRITISH JOURNAL OF SURGERY. vol. 90, 51-51.
Edwards JG, McLaren J, Jones JL, Waller DA, O'Byrne KJ(2003). Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura. BRIT J CANCER vol. 88, (10) 1553-1559.
10.1038/sj.bjc.6600920
Chauhan H, Abraham A, Phillips JRA, Pringle JH, Walker RA, Jones JL(2003). There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol vol. 56, (4) 271-276.
10.1136/jcp.56.4.271
Swinson DEB, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL et al.(2003). Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol vol. 21, (3) 473-482.
10.1200/JCO.2003.11.132
Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M et al.(2003). Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol vol. 65, (3) 361-376.
10.1016/S0006-2952(02)01517-4
Shaw JA, Udokang K, Mosquera J-M, Chauhan H, Jones JL, Walker RA(2002). Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol vol. 198, (4) 450-457.
10.1002/path.1230
Goddard JC, Sutton CD, Jones JL, O'Byrne KJ, Kockelbergh RC(2002). Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer. Eur Urol vol. 42, (5) 464-468.
10.1016/S0302-2838(02)00372-X
Mulligan KT, Shaw JA, Gordon LA, Holliday DL, Luckett JA, Walker RA, Jones JL(2002). Analysis of the tumour suppressor role of breast myoepithelial cells. J PATHOL vol. 198, 3A-3A.
Bamford WM, Saleem M, Kulbicki K, Walker RA, Jones JL(2002). Expression of matrilysin (MMP-7) protein in benign and malignant breast. J PATHOL vol. 198, 31A-31A.
Dhillon J, Pavlou G, Jones JL, Walker RA(2002). Expression of the cell adhesion molecule p120 differs between infiltrating ductal and infiltrating lobular carcinomas. J PATHOL vol. 198, 30A-30A.
Abrahams A, Chauhan H, Phillips J, Pringle JH, Walker RA, Jones JL(2002). There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in-situ and invasive breast lesions. J PATHOL vol. 198, 31A-31A.
Swinson DEB, Jones JL, Richardson D, Cox G, Edwards JG, O'Byrne KJ(2002). Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer vol. 37, (3) 235-240.
10.1016/S0169-5002(02)00172-1
Adams M, Jones JL, Walker RA, Pringle JH, Bell SC(2002). Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res vol. 62, (11) 3289-3297.
Swinson DEB, Jones JL, Cox G, Richardson C, Richardson D, Allen C, O'Byrne KJ(2002). Hypoxia inducible factor (HIF)-1 alpha in non-small cell lung cancer (NSCLC). BRIT J CANCER vol. 86, S28-S28.
Edwards JG, Swinson D, Jones JL, Cox G, O'Byrne KJ(2002). Tumour necrosis correlates with angiogenesis and is a prognostic factor in malignant mesothelioma. BRIT J CANCER vol. 86, S97-S97.
Swinson DEB, Lolljee J, Edwards JG, Jones JL, Cox G, Richardson D, O'Byrne KJ(2002). beta-catenin in non-small cell lung cancer (NSCLC). BRIT J CANCER vol. 86, S59-S60.
Cox G, Jones JL, Andi A, Abrams KR, O'Byrne KJ(2001). Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer. LUNG CANCER-J IASLC vol. 34, (3) 417-426.
10.1016/S0169-5002(01)00290-2
O'Byrne KJ, Cox G, Swinson D, Richardson D, Edwards JG, Lolljee J, Andi A, Koukourakis MI et al. (2001). Towards a biological staging model for operable non-small cell lung cancer. LUNG CANCER. vol. 34, S83-S89.
10.1016/S0169-5002(01)00352-X
Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, O'Byrne KJ(2001). Angiogenesis is an independent prognostic factor in malignant mesothelioma. BRIT J CANCER vol. 85, (6) 863-868.
10.1054/bjoc.2001.1997
Phillips JRA, Adams M, Gordon LA, Walker RA, Jones JL(2001). Characterisation of stromal changes in invasive and pre-invasive breast disease. J PATHOL vol. 195, 28A-28A.
Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR(2001). Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. NAT CELL BIOL vol. 3, (9) 823-830.
10.1038/ncb0901-823
Saleem M, Gordon LA, Adams M, Walker RA, Jones JL(2001). Effect of matrilysin (MMP-7) on breast cancer cell behaviour. J PATHOL vol. 195, 7A-7A.
Kovacs A, Dhillon J, Jones JL, Walker RA(2001). Expression of P- and N-cadherin in breast carcinomas. J PATHOL vol. 195, 27A-27A.
Banerjee AR, Jones JL, Birchall JP, Powe DG(2001). Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin. OTOL NEUROTOL vol. 22, (5) 579-581.
10.1097/00129492-200109000-00003
Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ(2001). A biological staging model for operable non-small cell lung cancer. Thorax vol. 56, (7) 561-566.
10.1136/thorax.56.7.561
Goddard JC, Sutton CD, Jones JL, O'Byrne KJ, Kockelbergh RC(2001). Reduction in immunohistochemical staining of thrombospondin-1 predicts progression in superficial bladder cancer. BRIT J CANCER vol. 85, 35-35.
Goddard JC, Sutton CD, Jones JL, Berry DP, O'Byrne KJ, Kockelbergh RC(2001). Reduction in thrombospondin 1 expression significantly correlates with disease progression in superficial bladder cancer. BRIT J SURG vol. 88, 8-8.
Return to top